Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results
暂无分享,去创建一个
N. Le | B. Gilks | Naveena Singh | A. Jeyarajah | S. Böhm | A. Faruqi | M. Lockley | I. Said | E. Brockbank | R. Wuntakal | N. Singh